SCHEMBL1375549

SCHEMBL1375549

COCCCNc1nc(N)ncc1Oc1ccc(Cl)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STK17A Q9UEE5 1/20 0.46
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
TLR7 Q9NYK1 2/20 0.39
KDM4E B2RXH2 4/20 0.39
HPGD P15428 2/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 3/20 0.39
TLR8 Q9NR97 1/20 0.39
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39
GAA P10253 1/20 0.39
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HSD17B10 Q99714 1/20 0.38
KCNH2 Q12809 3/20 0.38
SCN9A Q15858 3/20 0.38
SCN5A Q14524 2/20 0.38
NPC1 O15118 2/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7163367 0.93 RAB9A (0.42) STK17AMEN1KMT2ATLR7KDM4E
SCHEMBL1376217 0.86 NUDT1 (0.43) STK17AMEN1KMT2AMAPTLMNA
SCHEMBL5202871 0.85 STK17A (0.42) STK17AMEN1KMT2AMAPTLMNA
SCHEMBL5207386 0.84 STK17A (0.42) STK17AMEN1KMT2AMAPTKCNH2
SCHEMBL5204559 0.84 STK17A (0.41) STK17AMEN1KMT2AMAPTLMNA
SCHEMBL1376097 0.84 STK17A (0.41) STK17AMEN1KMT2AMAPTLMNA
SCHEMBL1376082 0.84 STK17A (0.41) STK17AMEN1KMT2AMAPTLMNA
SCHEMBL5205013 0.83 KCNH2 (0.40) STK17AMEN1KMT2AKDM4EHPGD
SCHEMBL7714115 0.82 STK17A (0.38) STK17AMEN1KMT2AALDH1A1MAPT
SCHEMBL1375420 0.81 KCNH2 (0.38) STK17AMEN1KMT2AKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4743463-B2 2011-08-10 JP claimed
US-6583148-B1 Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine KRENITSKY PHARMACEUTICALS, INC. 2003-06-24 US claimed
JP-2002541245-A 2002-12-03 JP claimed
EP-1165523-A1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES Krenitsky Pharmaceuticals, Inc. (US) 2002-01-02 EP claimed
WO-2000061562-A1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES KRENITSKY PHARMACEUTICALS INC. (US) 2000-10-19 WO claimed
US-6583148-B1 Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine KRENITSKY PHARMACEUTICALS, INC. 2003-06-24 US disclosed